1,050 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
JNJ Johnson & Johnson $139.96 $375.48B Uptrend
Article Searches
J&J Files Application for Darzalex Label Expansion in Europe http://www.zacks.com/stock/news/364217/jj-files-application-for-darzalex-label-expansion-in-europe?cid=CS-ZC-FT-364217 Mar 25, 2019 - J&J (JNJ) seeks an approval for Darzalex combo pertaining to the newly diagnosed, transplant-ineligible multiple myeloma patient population in the EU.
Biogen’s Big Bet in Alzheimer’s Disease Is a Bust https://www.fool.com/investing/2019/03/21/biogens-big-bet-in-alzheimers-disease-is-a-bust.aspx?source=iedfolrf0000001 Mar 21, 2019 - The big biotech's pivot from multiple sclerosis to Alzheimer's disease was dealt a decisive blow today.
Alkermes Focuses on Pipeline, Depends on Partners for Funds http://www.zacks.com/stock/news/362777/alkermes-focuses-on-pipeline-depends-on-partners-for-funds?cid=CS-ZC-FT-362777 Mar 21, 2019 - Alkermes (ALKS) has an impressive pipeline and is focused on the development of its candidates.
3 Dividend Stocks Ideal for Retirees https://www.fool.com/investing/2019/03/19/3-dividend-stocks-ideal-for-retirees.aspx?source=iedfolrf0000001 Mar 19, 2019 - These two popular dividend stocks, and one you've probably never heard of, should fit a retiree's portfolio.
Pharma Stock Roundup: Regulatory Updates From MRK, PFE, J&J, AGN & Others http://www.zacks.com/stock/news/359854/pharma-stock-roundup-regulatory-updates-from-mrk-pfe-jj-agn-others?cid=CS-ZC-FT-359854 Mar 15, 2019 - Regulatory updates from J&J (JNJ), Merck (MRK), Roche (RHHBY), Pfizer (PFE) and others.
J&J Seeks Approval for Darzalex in Expanded Patient Group http://www.zacks.com/stock/news/359663/jj-seeks-approval-for-darzalex-in-expanded-patient-group?cid=CS-ZC-FT-359663 Mar 15, 2019 - J&J (JNJ) files sBLA seeking approval for Darzalex combination regimen in newly- diagnosed, transplant ineligible multiple myeloma patient population.
Company News For Mar 15, 2019 http://www.zacks.com/stock/news/359794/company-news-for-mar-15-2019?cid=CS-ZC--359794 Mar 15, 2019 - Companies In The News Are: BA, DG, JNJ, WAGE
Johnson & Johnson (JNJ) Presents at Barclays Global Healthcare Broker Conference Call - (Transcript) https://seekingalpha.com/article/4248819-johnson-and-johnson-jnj-presents-barclays-global-healthcare-broker-conference-call-transcript?source=feed_sector_healthcare Mar 14, 2019 - Johnson & Johnson (NYSE:JNJ) Barclays Global Healthcare Conference Call March 14, 2019, 10:15 ET Company Participants Lesley Fishman - IR Chris DelOrefice - VP, IR Catherine Owen - President, Immu
Bayer Submits Application in EU for Prostate Cancer Drug http://www.zacks.com/stock/news/358754/bayer-submits-application-in-eu-for-prostate-cancer-drug?cid=CS-ZC-FT-358754 Mar 11, 2019 - Bayer (BAYRY) submits an MAA for darolutamide in EU for the treatment of patients with non-metastatic castration-resistant prostate cancer.
Can Smart Beta & Factor ETFs Beat the Market? http://www.zacks.com/stock/news/358467/can-smart-beta-factor-etfs-beat-the-market?cid=CS-ZC-FT-358467 Mar 08, 2019 - Here is what investors need to know about smart beta and factor strategies that combine the best aspects of active and passive investing.

Pages: 12345678910...105

<<<Page 5>